{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:57:23Z","timestamp":1781045843756,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1038\/s41388-026-03818-5","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:56:31Z","timestamp":1778154991000},"page":"2405-2418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0767-3937","authenticated-orcid":false,"given":"Yuning","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-6648","authenticated-orcid":false,"given":"Wenshuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7333-0372","authenticated-orcid":false,"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-2713","authenticated-orcid":false,"given":"Yuanfei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-3495","authenticated-orcid":false,"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9780-9027","authenticated-orcid":false,"given":"Shusha","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1441-3164","authenticated-orcid":false,"given":"Yujie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3343-3235","authenticated-orcid":false,"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-8706","authenticated-orcid":false,"given":"Zhenlong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-4314","authenticated-orcid":false,"given":"Gengxi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-0559","authenticated-orcid":false,"given":"Hongbiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"3818_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"3818_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3818_CR3","doi-asserted-by":"publisher","first-page":"e222246","DOI":"10.1001\/jamanetworkopen.2022.2246","volume":"5","author":"MM Desai","year":"2022","unstructured":"Desai MM, Cacciamani GE, Gill K, Zhang J, Liu L, Abreu A, et al. Trends in incidence of metastatic prostate cancer in the US. JAMA Netw Open. 2022;5:e222246.","journal-title":"JAMA Netw Open"},{"key":"3818_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41391-024-00906-z","volume":"28","author":"HD McManus","year":"2025","unstructured":"McManus HD, Dorff T, Morgans AK, Sartor O, Shore N, Armstrong AJ. Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. Prostate Cancer Prostatic Dis. 2025;28:672\u201383.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3818_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S1470-2045(22)00278-9","volume":"23","author":"N Agarwal","year":"2022","unstructured":"Agarwal N, McGregor B, Maughan BL, Dorff TB, Kelly W, Fang B, et al. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021). Lancet Oncol. 2022;23:899\u2013909.","journal-title":"Lancet Oncol"},{"key":"3818_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41392-021-00728-8","volume":"6","author":"J Kang","year":"2021","unstructured":"Kang J, Brajanovski N, Chan KT, Xuan J, Pearson RB, Sanij E. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy. Signal Transduct Target Ther. 2021;6:323.","journal-title":"Signal Transduct Target Ther"},{"key":"3818_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s11427-016-0018-0","volume":"59","author":"X Xu","year":"2016","unstructured":"Xu X, Xiong X, Sun Y. The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity. Sci China Life Sci. 2016;59:656\u201372.","journal-title":"Sci China Life Sci"},{"key":"3818_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","volume":"127","author":"V Ljungstr\u00f6m","year":"2016","unstructured":"Ljungstr\u00f6m V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2016;127:1007\u201316.","journal-title":"Blood"},{"key":"3818_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/jhbp.12012","volume":"31","author":"Y Sakano","year":"2024","unstructured":"Sakano Y, Matoba D, Noda T, Kobayashi S, Yamada D, Tomimaru Y, et al. Clinical significance of ribosomal protein S15 expression in patients with colorectal cancer liver metastases. J Hepatobiliary Pancreat Sci. 2024;31:611\u201324.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3818_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41392-023-01428-1","volume":"8","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Li Y, Zhu R, Feng R, Cui H, Yu X, et al. RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification. Signal Transduct Target Ther. 2023;8:224.","journal-title":"Signal Transduct Target Ther"},{"key":"3818_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tcb.2023.05.006","volume":"33","author":"X Chen","year":"2023","unstructured":"Chen X, Huang C. Chromatin-interacting RNA-binding proteins regulate transcription. Trends Cell Biol. 2023;33:625\u20139.","journal-title":"Trends Cell Biol"},{"key":"3818_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol. 2024;25:396\u2013415.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3818_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.molcel.2024.03.006","volume":"84","author":"JD Hao","year":"2024","unstructured":"Hao JD, Liu QL, Liu MX, Yang X, Wang LM, Su SY, et al. DDX21 mediates co-transcriptional RNA m(6)A modification to promote transcription termination and genome stability. Mol Cell. 2024;84:1711\u201326.e1711.","journal-title":"Mol Cell"},{"key":"3818_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature13923","volume":"518","author":"E Calo","year":"2015","unstructured":"Calo E, Flynn RA, Martin L, Spitale RC, Chang HY, Wysocka J. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2015;518:249\u201353.","journal-title":"Nature"},{"key":"3818_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302025","volume":"10","author":"Y Liao","year":"2023","unstructured":"Liao Y, Liu Y, Yu C, Lei Q, Cheng J, Kong W, et al. HSP90\u03b2 impedes STUB1-induced ubiquitination of YTHDF2 to drive sorafenib resistance in hepatocellular carcinoma. Adv Sci. 2023;10:e2302025.","journal-title":"Adv Sci"},{"key":"3818_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114404","volume":"444","author":"W Sun","year":"2025","unstructured":"Sun W, Cheng J, Zhao R, Xiang Y, Li Y, Yu C, et al. Ku70 targets the BRD3-MYC\/Cyclin D1 axis to drive hepatocellular carcinoma progression. Exp Cell Res. 2025;444:114404.","journal-title":"Exp Cell Res"},{"key":"3818_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41388-024-03209-8","volume":"44","author":"H Huang","year":"2025","unstructured":"Huang H, Zhuang X, Yin S, Sun W, Cheng J, Peng EY, et al. The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer. Oncogene. 2025;44:92\u2013104.","journal-title":"Oncogene"},{"key":"3818_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s11658-024-00665-8","volume":"29","author":"Z Shao","year":"2024","unstructured":"Shao Z, Liu S, Sun W, Zhuang X, Yin S, Cheng J, et al. SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration. Cell Mol Biol Lett. 2024;29:146.","journal-title":"Cell Mol Biol Lett"},{"key":"3818_CR19","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41388-021-01851-0","volume":"40","author":"Y Liao","year":"2021","unstructured":"Liao Y, Liu Y, Shao Z, Xia X, Deng Y, Cai J, et al. A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance. Oncogene. 2021;40:4291\u2013306.","journal-title":"Oncogene"},{"key":"3818_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107509","volume":"210","author":"X Zhuang","year":"2024","unstructured":"Zhuang X, Yin S, Cheng J, Sun W, Fang Z, Xiang Y, et al. METTL14-mediated m(6)A modification enhances the USP22-ER\u03b1 axis to drive breast cancer malignancy. Pharm Res. 2024;210:107509.","journal-title":"Pharm Res"},{"key":"3818_CR21","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/s41388-025-03620-9","volume":"44","author":"H Huang","year":"2025","unstructured":"Huang H, Xiang Y, Deng Y, Liu Q, Cai G, Lei Q, et al. WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression. Oncogene. 2025;44:4673\u201385.","journal-title":"Oncogene"},{"key":"3818_CR22","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.7150\/ijbs.67873","volume":"18","author":"Y Liao","year":"2022","unstructured":"Liao Y, Sun W, Shao Z, Liu Y, Zhong X, Deng Y, et al. A SIX1 degradation inducer blocks excessive proliferation of prostate cancer. Int J Biol Sci. 2022;18:2439\u201351.","journal-title":"Int J Biol Sci"},{"key":"3818_CR23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82:2344\u201353.","journal-title":"Cancer Res"},{"key":"3818_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2009.09.024","volume":"16","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell. 2009;16:369\u201377.","journal-title":"Cancer Cell"},{"key":"3818_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jcmm.17663","volume":"27","author":"X Yi","year":"2023","unstructured":"Yi X, Zhang C, Liu B, Gao G, Tang Y, Lu Y, et al. Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K\/Akt\/mTOR signalling pathway. J Cell Mol Med. 2023;27:403\u201311.","journal-title":"J Cell Mol Med"},{"key":"3818_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB. Prostate cancer: a review. JAMA. 2025;333:1433\u201346.","journal-title":"JAMA"},{"key":"3818_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1158\/1535-7163.MCT-09-1064","volume":"9","author":"V Fritz","year":"2010","unstructured":"Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avanc\u00e8s C, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther. 2010;9:1740\u201354.","journal-title":"Mol Cancer Ther"},{"key":"3818_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2021.106537","volume":"153","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang Y, Hao S, Qin Y, Wu Y. Knockdown of sterol O-acyltransferase 1 (SOAT1) suppresses SCD1-mediated lipogenesis and cancer progression in prostate cancer. Prostaglandins Other Lipid Mediat. 2021;153:106537.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"3818_CR29","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/onc.2013.206","volume":"32","author":"T Karantanos","year":"2013","unstructured":"Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene. 2013;32:5501\u201311.","journal-title":"Oncogene"},{"key":"3818_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.celrep.2013.08.049","volume":"5","author":"KE Sloan","year":"2013","unstructured":"Sloan KE, Bohnsack MT, Watkins NJ. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 2013;5:237\u201347.","journal-title":"Cell Rep"},{"key":"3818_CR31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1101\/gad.261792.115","volume":"29","author":"J Zheng","year":"2015","unstructured":"Zheng J, Lang Y, Zhang Q, Cui D, Sun H, Jiang L, et al. Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation. Genes Dev. 2015;29:1524\u201334.","journal-title":"Genes Dev"},{"key":"3818_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01404-9","volume":"20","author":"ZX Liang","year":"2021","unstructured":"Liang ZX, Liu HS, Xiong L, Yang X, Wang FW, Zeng ZW, et al. A novel NF-\u03baB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation. Mol Cancer. 2021;20:103.","journal-title":"Mol Cancer"},{"key":"3818_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/leu.2017.225","volume":"32","author":"T Girardi","year":"2018","unstructured":"Girardi T, Vereecke S, Sulima SO, Khan Y, Fancello L, Briggs JW, et al. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling. Leukemia. 2018;32:809\u201319.","journal-title":"Leukemia"},{"key":"3818_CR34","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1182\/bloodadvances.2020001717","volume":"5","author":"S Ntoufa","year":"2021","unstructured":"Ntoufa S, Gerousi M, Laidou S, Psomopoulos F, Tsiolas G, Moysiadis T, et al. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia. Blood Adv. 2021;5:2788\u201392.","journal-title":"Blood Adv"},{"key":"3818_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101811","volume":"23","author":"MJ Marcaida","year":"2020","unstructured":"Marcaida MJ, Kauzlaric A, Duperrex A, S\u00fclzle J, Moncrieffe MC, Adebajo D, et al. The human RNA helicase DDX21 presents a dimerization interface necessary for helicase activity. iScience. 2020;23:101811.","journal-title":"iScience"},{"key":"3818_CR36","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1093\/nar\/gkx380","volume":"45","author":"EKS McRae","year":"2017","unstructured":"McRae EKS, Booy EP, Moya-Torres A, Ezzati P, Stetefeld J, McKenna SA. Human DDX21 binds and unwinds RNA guanine quadruplexes. Nucleic Acids Res. 2017;45:6656\u201368.","journal-title":"Nucleic Acids Res"},{"key":"3818_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/ijo.2023.5522","volume":"62","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wang W, Kong P, Feng K, Liu C, Sun T, et al. New insights into lipid metabolism and prostate cancer (Review). Int J Oncol. 2023;62:74.","journal-title":"Int J Oncol"},{"key":"3818_CR38","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, Wang H, Yung MM, Chen F, Chan WS, Chan YS, et al. SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12:3534\u201352.","journal-title":"Theranostics"},{"key":"3818_CR39","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","volume":"30","author":"HH Liu","year":"2022","unstructured":"Liu HH, Xu Y, Li CJ, Hsu SJ, Lin XH, Zhang R, et al. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Mol Ther. 2022;30:2554\u201367.","journal-title":"Mol Ther"},{"key":"3818_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412244","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Yu X, Yang G, Chen X, Gong C, Han L, et al. Combined blockade of lipid uptake and synthesis by CD36 inhibitor and SCD1 siRNA is beneficial for the treatment of refractory prostate cancer. Adv Sci. 2025;12:e2412244.","journal-title":"Adv Sci"},{"key":"3818_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-020-00237-2","volume":"9","author":"SR Nagarajan","year":"2021","unstructured":"Nagarajan SR, Butler LM, Hoy AJ. The diversity and breadth of cancer cell fatty acid metabolism. Cancer Metab. 2021;9:2.","journal-title":"Cancer Metab"},{"key":"3818_CR42","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019;79:5355\u201366.","journal-title":"Cancer Res"},{"key":"3818_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10059-011-0043-5","volume":"31","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Choi H, Park SS, Chang C, Kim E. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Mol Cells. 2011;31:371\u20137.","journal-title":"Mol Cells"},{"key":"3818_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-018-0711-9","volume":"37","author":"H Ran","year":"2018","unstructured":"Ran H, Zhu Y, Deng R, Zhang Q, Liu X, Feng M, et al. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. J Exp Clin Cancer Res. 2018;37:54.","journal-title":"J Exp Clin Cancer Res"},{"key":"3818_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.trecan.2019.09.007","volume":"5","author":"B Peck","year":"2019","unstructured":"Peck B, Schulze A. Lipid metabolism at the nexus of diet and tumor microenvironment. Trends Cancer. 2019;5:693\u2013703.","journal-title":"Trends Cancer"},{"key":"3818_CR46","doi-asserted-by":"publisher","first-page":"e004616.","DOI":"10.1136\/jitc-2022-004616","volume":"10","author":"Y Katoh","year":"2022","unstructured":"Katoh Y, Yaguchi T, Kubo A, Iwata T, Morii K, Kato D, et al. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating \u03b2-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. J Immunother Cancer. 2022;10:e004616.","journal-title":"J Immunother Cancer"},{"key":"3818_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:315.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03818-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:02:48Z","timestamp":1781042568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03818-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":47,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,7,1]]}},"alternative-id":["3818"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03818-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Foshan First People\u2019s Hospital (Approval No. [2025] 213). Written informed consent was obtained from all patients prior to tissue collection. All animal experiments were performed in accordance with institutional guidelines and were approved by the Experimental Animal Ethics Committee of Guangzhou Medical University (Approval No. GY2022-235).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}